[ Price : $8.95]
Merck reports positive Phase 3 results for its oral PCSK9 inhibitor enlicitide, showing LDL-cholesterol reductions approaching 60%...[ Price : $8.95]
Fresenius Kabi recalls three lots of its famotidine injection after reserve samples from one lot tested out of specification for e...[ Price : $8.95]
A group of leaders from government, academia, and the pharmaceutical industry call for sweeping federal action to stabilize the U....[ Price : $8.95]
Cogent Biosciences reports positive data from a Phase 3 study of its KIT inhibitor bezuclastinib, saying that the drug combined wi...[ Price : $8.95]
FDA cites Medispray Laboratories, a finished drug product manufacturer based in Ponda, Goa, India, for significant lapses in its q...[ Price : $8.95]
Intellia Therapeutics reports that a patient who experienced liver toxicity after being administered the companys CRISPR-based the...[ Price : $8.95]
FDA approves Janssens Darzalex Faspro (daratumumab and hyaluronidase-fihj) for adults with high-risk smoldering multiple myeloma (...[ Price : $8.95]
Senate Democrats say they are worried that FDA and HHS may rely on partisan junk science during its recently announced review of t...